Elevance Health (ELV) Stock Statistics & Valuation Metrics

Elevance Health has a market cap or net worth of $74.87B. The enterprise value is $97.05B.

Elevance Health has 217,162,380 shares outstanding. The number of shares has decreased by -2.65% in one year.

Elevance Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 6.65%.

The current PE Ratio of Elevance Health is 9.1. Elevance Health’s PEG ratio is -5.63.

In the last 12 months, Elevance Health had revenue of 199.13B and earned 5.66B in profits. Earnings per share was 25.18.

In the last 12 months, operating cash flow was 7.61B and capital expenditures -1.16B, giving a free cash flow of 6.45B billion.

Elevance Health pays an annual dividend of $1.71, resulting in a dividend yield of 1.99%

Elevance Health upcoming earnings date is Jul 22, 2026, Before Open (Confirmed).

Elevance Health as a current ratio of 1.24, with Debt / Equity ratio of 72.53%

In the past 12 months, Elevance Health has paid 1.05B in taxes.

Elevance Health EV to EBITDA ratio is 10.51, with an EV/FCF ratio of 31.98.

Elevance Health has $35.56B in cash and marketable securities with $31.84B in debt, giving a net cash position of $3.72B billion.

Gross margin is 23.16%, with operating margin of 4.07%, and net profit margin of 2.84%.

The average price target for Elevance Health is $376.78, which is 11.43% higher than the current price. The consensus rating is Moderate Buy